Corporate Profile
bluebird bio is a clinical-stage biotechnology company focused on transforming the lives of patients with severe genetic and orphan diseases using gene therapy. The company’s mission is to advance the care of patients with life threatening diseases worldwide. Headquartered in Cambridge, Massachusetts, bluebird bio has operations in the U.S. and Europe.
Stock Quote
BLUE (Common Stock)
ExchangeNASDAQ GS (US Dollar)
Change (%) Stock is Up 3.64 (3.84%)
Data as of 01/29/15 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent NewsMore >>
01/29/15bluebird bio Announces Transition of Chief Scientific OfficerPrinter Friendly Version
01/06/15bluebird bio to Present at the 33rd Annual J.P. Morgan Healthcare ConferencePrinter Friendly Version
12/15/14bluebird bio Announces Pricing of Public Offering of Common StockPrinter Friendly Version
12/15/14bluebird bio Announces Proposed Public Offering of Common StockPrinter Friendly Version
Upcoming EventsMore >>
There are currently no events scheduled.

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.